Skip to main content
. 2017 Mar 29;37(5):2603–2610. doi: 10.3892/or.2017.5536

Figure 3.

Figure 3.

Immune-active status was significantly high in early-stage endometrial cancer. (A-C) Comparison of mRNA expression levels of CD8, GZMA and HLA-A in early- (stage I/II) and advanced- (stage III/IV) stages (A), in grade 1/2 and grade 3 tumors (B) and in young (≤61 years) and elderly (>61 years) patients (C) by Mann-Whitney test.